Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Folate testing. [Protocol]
2022	National Institute for Health and Care Excellence (NICE)	Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus). NICE interventional procedures guidance 727
2022	Swiss Federal Office of Public Health (FOPH)	Sedative-hypnotic drugs for the treatment of primary chronic insomnia disorder
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Revascularisation versus optimal medical therapy (OMT) for the treatment of chronic coronary syndrome (CCS). [Protocol]
2022	National Institute for Health and Care Excellence (NICE)	Endoanchoring systems in endovascular aortic aneurysm repair. NICE interventional procedures guidance 725
2022	Swiss Federal Office of Public Health (FOPH)	Levothyroxine for patients diagnosed with subclinical hypothyroidism
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Denosumab (Prolia) for the treatment of osteoporosis
2022	National Institute for Health and Care Excellence (NICE)	Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis. NICE interventional procedures guidance 726
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Calcitonin gene-related peptide antagonists for the prevention of migraine [Protocol]
2022	National Institute for Health and Care Excellence (NICE)	Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome. NICE interventional procedures guidance 724
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Oral anticoagulants for prevention of stroke and systemic embolism in people with non-valvular atrial fibrillation. [Protocol]
2022	National Institute for Health and Care Excellence (NICE)	Liposuction for chronic lymphoedema. NICE interventional procedures guidance 723
2022	National Institute for Health and Care Excellence (NICE)	Intramedullary distraction for upper limb lengthening. NICE interventional procedures guidance 722
2022	National Institute for Health and Care Excellence (NICE)	Liposuction for chronic lipoedema. NICE interventional procedures guidance 721
2022	NIHR Health Technology Assessment programme	Endovascular stent grafting and open surgical replacement for chronic thoracic aortic aneurysms: a systematic review and prospective cohort study
2022	NIHR Health Technology Assessment programme	Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis
2022	National Institute for Health and Care Excellence (NICE)	Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis. NICE interventional procedures guidance 720
2022	Health Technology Wales (HTW)	Virtual reality interventions for the management of pain associated with medical procedures
2022	National Institute for Health and Care Excellence (NICE)	Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomach. NICE interventional procedures guidance 717
2022	NIHR Health Technology Assessment programme	A large randomised assessment of the relative cost-effectiveness of different classes of drugs for Parkinson's disease (PD MED)
2022	National Institute for Health and Care Excellence (NICE)	Intramedullary distraction for lower limb lengthening. NICE interventional procedures guidance 718
2022	Agency for Care Effectiveness (ACE)	Negative pressure wound therapy for wound management in patients with diabetes (type 1 and 2)
2022	National Institute for Health and Care Excellence (NICE)	Endoscopic balloon dilation for subglottic or tracheal stenosis. NICE interventional procedures guidance 719
2022	NIHR Health Technology Assessment programme	Telaprevir for the treatment of genotype 1 chronic hepatitis C
2022	NIHR Health Technology Assessment programme	Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
2022	Agency for Care Effectiveness (ACE)	Brentuximab vedotin for treating T-cell lymphoma
2022	National Institute for Health and Care Excellence (NICE)	Stereotactic radiosurgery for trigeminal neuralgia. NICE interventional procedures guidance 715
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for treating advanced urothelial carcinoma
2022	National Institute for Health and Care Excellence (NICE)	Microwave ablation for primary or metastatic cancer in the lung. NICE interventional procedures guidance 716
2022	Agency for Care Effectiveness (ACE)	Ruxolitinib for treating polycythaemia vera
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for treating early or advanced HER2-positive breast cancer
2022	Health Information and Quality Authority (HIQA)	Descriptive analysis of COVID-19 epidemiological indicators and associated contextual factors in European countries
2022	Agency for Care Effectiveness (ACE)	Poly (ADP-ribose) polymerase inhibitors for treating BRCA-mutated, HER2-negative advanced breast cancer
2022	Agency for Care Effectiveness (ACE)	Polatuzumab vedotin for treating relapsed or refractory diffuse large B-cell lymphoma
2022	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Pegcetacoplan (paroxysmal nocturnal haemoglobinuria, pretreated patients)]
2022	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Migalastat (new therapeutic indication: Fabry disease, 12 to < 16 years)]
2022	Agency for Care Effectiveness (ACE)	Daratumumab-based regimens for newly diagnosed multiple myeloma
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Microwave ablation for liver tumours
2022	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Odevixibat (progressive familial intrahepatic cholestasis)]
2022	Agency for Care Effectiveness (ACE)	Acalabrutinib, bortezomib and ibrutinib for treating mantle cell lymphoma
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Hepatic and portal vein embolization prior to major hepatectomy
2022	Agency for Care Effectiveness (ACE)	Review of cancer drugs for chronic lymphocytic leukaemia
2022	Agency for Care Effectiveness (ACE)	Osimertinib for treating EGFR mutation-positive non-small-cell lung cancer
2022	Norwegian Institute of Public Health (NIPH)	Molecular tests for detection of PIK3CA mutations in men and postmenopausal women with HR+/HER2–, locally advanced or metastatic breast cancer: a health technology assessment
2022	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Tafasitamab (diffuse large B-cell lymphoma (DLBCL), combination with lenalidomide)]
2022	Norwegian Institute of Public Health (NIPH)	Zephyr® valves system in the treatment of emphysema: a single technology assessment
2022	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Vosoritide (achondroplasia, ≥ 2 years)]
2022	Agency for Care Effectiveness (ACE)	Cooral System for the prevention of oral mucositis
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Breast cancer risk assessment tools
2022	Agency for Care Effectiveness (ACE)	Magnetic resonance image guided radiation therapy for patients with cancer
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Testosterone reference ranges for gender diverse individuals
2022	Agency for Care Effectiveness (ACE)	Robot-assisted endovascular intervention systems for coronary artery disease and other vascular diseases
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Structured screening questionnaires for alcohol misuse/alcohol use disorders
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Home-based oral nutritional supplements in cancer patients who require modification of the usual ordinary diet due to mucositis]
2022	Agency for Care Effectiveness (ACE)	Nicotine replacement therapies to aid smoking cessation
2022	Agency for Care Effectiveness (ACE)	Ciclosporin 0.1% eye drops for treating severe keratitis in dry eye disease
2022	Agency for Care Effectiveness (ACE)	Sodium zirconium cyclosilicate for treating hyperkalaemia
2022	Agency for Care Effectiveness (ACE)	Dolutegravir with lamivudine for treating Human Immunodeficiency Virus type 1 (HIV-1) infection
2022	Penn Medicine Center for Evidence-based Practice (CEP)	Clinical utility of inpatient fall risk assessment
2022	Agency for Care Effectiveness (ACE)	Acarbose for treating type 2 diabetes mellitus
2022	Agency for Care Effectiveness (ACE)	Ciclosporin 0.1% eye drops for treating severe vernal keratoconjunctivitis
2022	Norwegian Institute of Public Health (NIPH)	Tests for the detection of NTRK gene fusions in patients with locally advanced or metastatic solid tumours
2022	Agency for Care Effectiveness (ACE)	Recombinant blood products for prophylaxis and management of haemophilia A and B
2022	Austrian Institute for Health Technology Assessment (AIHTA)	CAR-T cell-therapies in development, update 2022
2022	Agency for Care Effectiveness (ACE)	GLP-1 receptor agonist injections for treating type 2 diabetes mellitus
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Regulation and financing of prenatal screening and diagnostic examinations for fetal anomalies in selected European countries
2022	NIHR Health Technology Assessment programme	Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Quality improvement strategies in trauma care: review and proposal of 31 novel quality indicators
2022	NIHR Health Services and Delivery Research programme	Components of interventions to reduce restrictive practices with children and young people in institutional settings: the Contrast systematic mapping review
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Achieving safe surgery after COVID-19 vaccination
2022	NIHR Health Services and Delivery Research programme	Assessment and management pathways of older adults with mild cognitive impairment: descriptive review and critical interpretive synthesis
2022	Health Information and Quality Authority (HIQA)	Health technology assessment of metabolic surgery for the treatment of comorbid type 2 diabetes and obesity
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Impact of COVID-19, gender, race, specialty and seniority on mental health during surgical training: an international study
2022	Institute for Clinical and Economic Review (ICER)	Betibeglogene autotemcel for beta thalassemia: effectiveness and value
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Mesh versus non-mesh repair of groin hernias: a rapid review
2022	Institute for Clinical and Economic Review (ICER)	Special assessment of outpatient treatments for COVID-19
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Update: guidelines on the preoperative diagnostic workup for COVID-19
2022	Institute for Clinical and Economic Review (ICER)	Tirzepatide for type 2 diabetes
2022	Malaysian Health Technology Assessment (MaHTAS)	Tertiary care virtual online consultation between doctor and patient
2022	Adelaide Health Technology Assessment (AHTA)	Whole genome sequencing for the diagnosis of mitochondrial disease
2022	NIHR Health Technology Assessment programme	Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT
2022	Adelaide Health Technology Assessment (AHTA)	Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia
2022	Ontario Health	Transcatheter valve-in-valve implantation for degenerated mitral or tricuspid bioprosthetic valves: a health technology assessment
2022	Ontario Health	Molecular testing for thyroid nodules with atypical cells of indeterminate significance
2022	Canadian Agency for Drugs and Technologies in Health (CADTH)	Adalimumab for the treatment of adults with non-infectious uveitis
2022	Ontario Health	Genetic testing for familial hypercholesterolemia
2022	NIHR Health Technology Assessment programme	One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT
2022	Canadian Agency for Drugs and Technologies in Health (CADTH)	Adalimumab for the treatment of pediatric populations with non-infectious uveitis
2022	Ontario Health	Pre-surgical nasal decolonization of staphylococcus aureus
2022	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Treatments for extreme nausea and vomiting in pregnancy (hyperemesis gravidarum)]
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022
2022	Austrian Institute for Health Technology Assessment (AIHTA)	Long COVID care pathways and structures: an updated scoping review
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Stakeholders' perspectives of mobile x-ray services in support of healthcare-in-place in residential aged care facilities: a qualitative study
2022	NIHR Health Technology Assessment programme	Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Residents' perspectives of mobile X-ray services in support of healthcare-in-place in residential aged care facilities: a qualitative study.
2022	NIHR Health Services and Delivery Research programme	Perioperative exercise programmes to promote physical activity in the medium to long term: systematic review and qualitative research
2022	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	The utilization and national variation of plain x-ray services by Australian residents of long-term care facilities
2021	Scottish Medicines Consortium (SMC)	Fostamatinib treatment of chronic immune thrombocytopenia in adult patients who are refractory to other treatments
2021	Health Information and Quality Authority (HIQA)	Rapid review of public health guidance on protective measures for vulnerable groups in the context of COVID-19
2021	National Institute for Health and Care Excellence (NICE)	Crizanlizumab for preventing sickle cell crises in sickle cell disease. NICE technology appraisal guidance 743